Non-invasive MRI Subclassification of Heptocellular Carcinoma - HepCaSt-Study

UnknownOBSERVATIONAL

Enrollment

150

Participants

Timeline

Start Date

January 1, 2022

Primary Completion Date

January 1, 2024

Study Completion Date

July 1, 2024

Conditions

HCCHepatocellular CarcinomaMRI

Interventions

DRUG

MRI using a hepatobiliary phase contrast agent (Gd-EOB-DPTA)

MRI of the liver accoring to our institutional daily routine protocol

Trial Locations (1)

RECRUITING

Charité - University Medicine Berlin, Berlin